Lavior, Inc. – FDA Inspection, Oct 26, 2018

Record Details

This FDA Inspection record concerns Lavior, Inc., with an inspection on October 26, 2018, issued by the Florida District Office, covering human drugs.

Company: Lavior, Inc.
Inspection Date: October 26, 2018
Product Type: Human Drugs
Office: Florida District Office
Person: Christopher R. Czajka (FDA Associated Person)

View Company Profile

ID · fc7becec-8ec3-4a99-9ec3-2bccf0c51acf

Inspection Facts

Inspection number: 1070159
FDA center: Human Drugs
Project area: Unapproved and Misbranded Drugs
Outcome: Form 483 issued

FDA Citations

21 CFR 211.137(a)Expiration date lacking
21 CFR 211.142(b)Storage under appropriate conditions
21 CFR 211.160(b)Scientifically sound laboratory controls
21 CFR 211.165(a)Testing and release for distribution
21 CFR 211.22(d)Procedures not in writing, fully followed
21 CFR 211.25(a)Training--operations, GMPs, written procedures

Full citation text and observation details available on the Dashboard.

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Lavior, Inc.

FDA Inspection

Lavior, Inc.October 26, 2018